ADI vs AVGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ADI's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. While the company exhibits strong profitability (23.02% net margin, 33.07% operating margin) and impressive revenue and earnings growth (30.4% and 116.7% YoY), its valuation is extremely stretched, trading at a forward P/E of 23.68 and current P/E of 55.85—well above sector averages. The Graham Number ($92.38) and intrinsic value ($161.66) suggest significant upside potential, but the current price of $306.07 reflects a premium driven by high growth expectations, not fundamental undervaluation. Insider selling activity over the past six months (13 transactions, $25.96M in sales) further undermines confidence in near-term prospects.
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
Compare Another Pair
Related Comparisons
ADI vs AVGO: Head-to-Head Comparison
This page compares Analog Devices, Inc. (ADI) and Broadcom Inc. (AVGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.